#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA2038011	B	Inhibition of N-terminal MBP-tagged human alpha2beta2 CK2 expressed in Escherichia coli using casein as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay	Homo sapiens	47		assay format	Scientific Literature
2.	ALA1937305	B	Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assay	Homo sapiens	37		protein complex format	Scientific Literature
3.	ALA2014909	B	Inhibition of CK2a2/b at 10 uM		1		protein complex format	Scientific Literature
4.	ALA1114864	B	Inhibition of CK2 alpha2/beta at 5 uM		1		protein complex format	Scientific Literature
5.	ALA1105946	B	Inhibition of CK2a2/b at 5 uM		1		protein complex format	Scientific Literature
6.	ALA3882378	B	Inhibition of human recombinant CK2 alpha'/beta holoenzyme using alpha-casein as substrate after 10 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	Homo sapiens	1		protein complex format	Patent Bioactivity Data
7.	ALA4414165	B	Inhibition of recombinant human GST-tagged CK2alpha2beta2 up to 3 uM in presence of ATP by radiometric kinase assay	Homo sapiens	1		protein complex format	Scientific Literature
8.	ALA4613134	B	ATP competitive inhibition of recombinant human CK2alpha2 (1 to 335 residues)/CK2beta2 (1 to 193 residues) expressed in Escherichia coli BL21(DE3) using RRRDDDSDDD as substrate preincubated for 10 mins followed by substrate addition and measured after 5 mins in presence of varying level of [gamma-32P]ATP by Dixon-plot analysis	Homo sapiens	3		assay format	Scientific Literature
9.	ALA4613135	B	Ratio of Ki for ATP uncompetitive inhibition to Ki for ATP competitive inhibition of recombinant human CK2alpha2 (1 to 335 residues)/CK2beta2 (1 to 193 residues) expressed in Escherichia coli BL21(DE3)	Homo sapiens	3		assay format	Scientific Literature